Merck KGaA (ETR:MRK) Trading 0.5% Higher – Should You Buy?

Shares of Merck KGaA (ETR:MRK) traded up 0.5% during mid-day trading on Thursday . The stock traded as high as €118.40 and last traded at €117.15. 292,655 shares were traded during trading, The stock had previously closed at €116.55.

Merck KGaA Stock Performance

The company has a market capitalization of $52.17 billion, a price-to-earnings ratio of 19.24, a price-to-earnings-growth ratio of 2.37 and a beta of 0.72. The firm has a fifty day simple moving average of €115.79 and a 200 day simple moving average of €117.83. The company has a debt-to-equity ratio of 41.86, a current ratio of 1.46 and a quick ratio of 0.72.

About Merck KGaA

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector. This segment provides drug manufacturers with process development expertise and technologies, such as continuous bioprocessing; testing kits and services; reagents and services; testing solutions that analyze air, water, and soil; and testing and tools, as well as products that help test nutritional value and identify quality inconsistencies.